Cargando…
PLK1 (polo like kinase 1) inhibits MTOR complex 1 and promotes autophagy
Mechanistic target of rapamycin complex 1 (MTORC1) and polo like kinase 1 (PLK1) are major drivers of cancer cell growth and proliferation, and inhibitors of both protein kinases are currently being investigated in clinical studies. To date, MTORC1′s and PLK1′s functions are mostly studied separatel...
Autores principales: | Ruf, Stefanie, Heberle, Alexander Martin, Langelaar-Makkinje, Miriam, Gelino, Sara, Wilkinson, Deepti, Gerbeth, Carolin, Schwarz, Jennifer Jasmin, Holzwarth, Birgit, Warscheid, Bettina, Meisinger, Chris, van Vugt, Marcel A. T. M., Baumeister, Ralf, Hansen, Malene, Thedieck, Kathrin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5361591/ https://www.ncbi.nlm.nih.gov/pubmed/28102733 http://dx.doi.org/10.1080/15548627.2016.1263781 |
Ejemplares similares
-
A systems study reveals concurrent activation of AMPK and mTOR by amino acids
por: Pezze, Piero Dalle, et al.
Publicado: (2016) -
Computational Design of Targeted Inhibitors of Polo-Like Kinase 1 (Plk1)
por: Jani, Krupa S., et al.
Publicado: (2012) -
Polo-like kinase 1 (Plk1): an Unexpected Player in DNA Replication
por: Song, Bing, et al.
Publicado: (2012) -
Role of Polo-like Kinases Plk1 and Plk4 in the Initiation of Centriole Duplication—Impact on Cancer
por: Hoffmann, Ingrid
Publicado: (2022) -
Regulating a key mitotic regulator, polo‐like kinase 1 (PLK1)
por: Colicino, Erica G., et al.
Publicado: (2018)